Cognitive Behavioural Therapy/Metacognitive Therapy for Low Self Esteem

NCT06866639 | Not Yet Recruiting

• 1 other identifier: LSE06064685
• Study Type: interventional
• Target: 20
• Locations: 1 country
• Sites: 1

Brief Summary

The goal for this clinical trial is to explore the effect of CBT/MCT on the treatment of low self esteem. 20 patients with low self-esteem will be selected and distributed into two either MCT or a CBT We aim in this study to (1) evaluate the accessibility and effectiveness of MCT and CBT in treating low self-esteem, (2) investigate the patterns of change and the mechanisms of action involved during treatment, and (3) examine the impact of meta-cognitions and neuropsychologial processes in the treatment response and any relapse prevention of low self-esteem.

Conditions

Psychological Disorders

Keywords

low self esteem; cognitive behavioural therapy; metacognitive therapy; depressive symptoms; anxiety symptoms

Outcome Measures

Primary Outcomes (1)

• Rosenberg Self Esteem Scale

  The purpose of the 10 item RSE scale is to measure self-esteem.The scale ranges from 0-30. Scores between 15 and 25 are within normal range; scores below 15 suggest low self-esteem

  Baseline scores each week over two weeks before pre-treatment, pre-treatment, each session each week over 8 weeks , post-treatment (8 weeks), and six months follow up

Secondary Outcomes (2)

• GAD-7

  Baseline scores each week over two weeks before pre-treatment, pre-treatment, each session each week over 8 weeks, post-treatment (8 weeks) and six months follow up

• PHQ-9

  Baseline scores each week over two weeks before pre-treatment, pre-treatment, each session each week over 8 weeks , post-treatment (8 weeks) and six months follow up

Other Outcomes (9)

• Penn State Worry Questionnaire

  Pre-, post-treatment (8 weeks) and six months follow up

• Inventory of Interpersonal Problems (IIP-64)

  Pre-, post-treatment (8 weeks) and six months follow up after treatment

• Ruminative Response Scale

  Pre-, post-treatment (8 weeks) and six months follow up after treatment

Study Arms (2)

Cognitive behavioral therapy

EXPERIMENTAL

Cognitive behavioral therapy

Behavioral: Cognitive behavioral therapy

Metacognitive therapy

EXPERIMENTAL

Metacognitive therapy

Behavioral: Metacognitive therapy

Interventions

Cognitive behavioral therapy BEHAVIORAL

The CBT is based on the treatment manual written by Fennell (1997). The patients receiving CBT will be treated for 8 sessions, with weekly session of 45-60 minutes duration.

Cognitive behavioral therapy

Metacognitive therapy BEHAVIORAL

The meta-cognitive treatment program is based on Wells's metacognitive therapy (Wells, 2013). The patients receiving meta-cognitive therapy will be treated for 8 sessions, with weekly session of 45-60 minutes duration.

Metacognitive therapy

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Signed written informed consent obtained prior to entry in the study.
• Scores below 15 on the Rosenberg Self-esteem Scale (RSE)
• years or older.

You may not qualify if:

• Psychosis
• Bipolar type 1
• Current suicide intent
• PTSD
• Cluster A or cluster B personality disorder
• Substance dependence

Sponsors & Collaborators

• University of Oslo: lead
• Norwegian University of Science and Technology: collaborator

Study Sites (1)

Department of Psychology, University of Oslo

Oslo, 0373, Norway

Location

MeSH Terms

Conditions

Mental Disorders; Depression; Anxiety Disorders

Interventions

Cognitive Behavioral Therapy

Condition Hierarchy (Ancestors)

Behavioral Symptoms; Behavior

Intervention Hierarchy (Ancestors)

Behavior Therapy; Psychotherapy; Behavioral Disciplines and Activities

Study Officials

• Roger Hagen, Professor

  University of Oslo

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Roger Hagen, Professor

CONTACT

+4748109789; roger.hagen@psykologi.uio.no

Leif Edward Ottesen Kennair, Professor

CONTACT

+4790557004; Kennair@ntnu.no

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor

Model Details: The first group (n=10) will be treated with MCT, whereas the second group (n = 10) will be treated with CBT

Study Record Dates

• First Submitted: February 13, 2025
• First Posted: March 10, 2025
• Study Start: March 1, 2025
• Primary Completion: December 1, 2025
• Study Completion (Estimated): August 1, 2026
• Last Updated: March 10, 2025

Record last verified: 2025-02

Data Sharing

• IPD Sharing: Will not share

Locations

NO (1)